Explore Decure’s sourcing portfolio across injectables, tablets, capsules, dry syrups, topical formulations and specialized therapeutic ranges, with multiple strengths, compositions and dosage-form options for institutional and commercial requirements.
8+Product Categories
500+Product Variants
MultipleDosage Forms
GMPQuality Sourced
Sterile injectable formulations for institutional and hospital requirements.
Beta-Lactam and Non-Beta-Lactam formulations across therapeutic categories.
Hard-shell capsule formulations in multiple strengths and compositions.
Paediatric and adult oral liquid and dry-syrup formulation options.
Creams, ointments and other topical dosage-form requirements.
Formulations supporting diabetes-management sourcing requirements.
Cardiovascular formulations across common dosage forms and strengths.
Page 9 of 22
Uncoated Tablet
Diclofenac Sodium 50 mg + Paracetamol 325 mg Uncoated Tablet is a uncoated tablet formulated with Diclofenac Sodium 50 mg + Paracetamol 325 mg. The active ingredient profile is Diclofenac Sodium; Paracetamol, placing the product in the nsaid + analgesic c
Capsule
Diclofenac Sodium 50mg + Thiocolchicoside 4mg Capsule is a capsule formulated with Diclofenac Sodium 50mg + Thiocolchicoside 4mg. The listed active ingredient profile is Diclofenac Sodium; Thiocolchicoside, placing the product in the pain / musculoskeleta
Enteric-Coated Tablet
Divalproex Sodium 125 mg Enteric-Coated Tablet is a enteric-coated tablet formulated with 125 mg. The active ingredient profile is Divalproex Sodium, placing the product in the anticonvulsant / mood-stabilizing agent category. Divalproex Sodium is an anti
Extended-Release Tablet
Divalproex Sodium Extended-Release 1000 mg Tablet is a extended-release tablet formulated with 1000 mg. The active ingredient profile is Divalproex Sodium, placing the product in the anticonvulsant / mood-stabilizing agent category. Divalproex Sodium is a
Topical Formulation
Dlclofenac Dlethylamine 1.16%w/w + Diclofenac Sodlum V/w/w + linseed Ol 37%w/w + Methyl Sallcylate 10%w/w + Menthol 57%w/w + Benzyl Alcohol 1%w/w is a topical formulation formulated with Dlclofenac Dlethylamine 1.16%w/w + Diclofenac Sodlum V/w/w + linseed
Capsule
Doxycycline 100 mg + Lactic acid 5 Bilion spores Capsule is a capsule formulated with Doxycycline 100 mg + Lactic acid 5 Bilion spores. The listed active ingredient profile is Doxycycline; Lactic acid Bilion spores, placing the product in the antibacteria
Capsule
Doxycycline 100mg capsules is a capsule formulated with Doxycycline 100mg. The listed active ingredient profile is Doxycycline, placing the product in the antibacterial category. The active ingredient is an antibacterial medicine intended for susceptible
Hard Gelatin Capsule
Doxylamine Succinate USP 10 mg + Pyridoxine Hcl IP 10 mg + Folic Acid IP 2.5 mg (Hard Gelatin Cap) is a hard gelatin capsule formulated with Doxylamine Succinate USP 10 mg + Pyridoxine Hcl IP 10 mg + Folic Acid IP 2.5 mg ( Cap). The listed active ingredie
Uncoated Tablet
Drotaverine 40 mg Uncoated Tablet is a uncoated tablet formulated with 40 mg. The active ingredient profile is Drotaverine, placing the product in the antispasmodic category. The active ingredient is an antispasmodic intended to reduce smooth-muscle spasm
Tablet
Drotaverine 80 mg + Aceclofenac 100 mg Tablet is a tablet formulated with Drotaverine 80 mg + Aceclofenac 100 mg. The active ingredient profile is Drotaverine; Aceclofenac, placing the product in the antispasmodic + nsaid combination category. The formula
Film-Coated Tablet
Drotaverine Hydrochloride 80 mg + Mefenamic Acid 250 mg Film-Coated Tablet is a film-coated tablet formulated with Drotaverine Hydrochloride 80 mg + Mefenamic Acid 250 mg. The active ingredient profile is Drotaverine Hydrochloride; Mefenamic Acid, placing
Topical Formulation
Eberconazole Nitrate 1%w/w is a topical formulation formulated with Eberconazole Nitrate 1%w/w. The listed active ingredient profile is Eberconazole Nitrate w/w, placing the product in the topical antifungal / dermatology category. The formulation contain
Topical Formulation
Erythromycin 2% w/w + Isotretinoin 0.05 % w/w is a topical formulation formulated with Erythromycin 2% w/w + Isotretinoin 0.05 % w/w. The listed active ingredient profile is Erythromycin % w/w; Isotretinoin % w/w, placing the product in the topical antiba
Hard Gelatin Capsule
Esomeprazole (EC) IP 40 mg + Levosulpiride (SR) 75 mg (Hard Gelatin Cap) is a hard gelatin capsule formulated with Esomeprazole (EC) IP 40 mg + Levosulpiride (SR) 75 mg ( Cap). The listed active ingredient profile is Esomeprazole; Levosulpiride, placing t
Capsule
Esomeprazole 40 mg (EC) + Domperidone 30(SR) mg Capsule is a capsule formulated with Esomeprazole 40 mg (EC) + Domperidone 30(SR) mg. The listed active ingredient profile is Esomeprazole; Domperidone, placing the product in the gastrointestinal / acid-pep
Hard Gelatin Capsule
Esomeprazole 40 mg + Levosulpiride 75 mg Capsules (Each Hard Gelatin Capsules) is a hard gelatin capsule formulated with Esomeprazole 40 mg + Levosulpiride 75 mg (Each ). The listed active ingredient profile is Esomeprazole; Levosulpiride, placing the pro
GMP Certified Manufacturers
Wide Product Portfolio
Multiple Dosage Forms
Global Supply Network
Regulatory Documentation
Competitive PricingOur sourcing experts are ready to help with custom requirements, supply availability and regulatory documentation.
